Matt Hoffman

The ZTlido patch utilizes a 36-mg dose of lidocaine, compared to the 700-mg dose used by other available patches.

Time constraints, confusion about the definition, and a litany of other factors all played a role in the collection of vital drug AE data.

The guidelines provide best-practices for physicians in these situations, though many physicians may be hesitant to provide aid during in-flight emergencies.

Children who had long-term exposure to 'greener' neighborhoods had higher brain volume in several regions. Additionally, peak volumes in some of the clusters associated with greenness also predicted better scores for cognitive tests.

In combination with low-dose hormone therapy, elagolix reduced heavy menstrual bleeding in 68.5% of women with uterine fibroids.

Medtronic had both its Guardian Sensor 3 CGM system and it's Resolute Onyx 2.0 mm drug-eluting stent approved by the FDA.

Those in deprived populations—the homeless, those with substance abuse disorder, sex workers, and prisoners—have a significantly higher rate of all-cause mortality than their counterparts.

For medical school students, choosing a specialty is a decision that carries a lifetime's worth of weight. What factors go into that choice?

Study data revealed that the patients who received a 2-week course of the antibiotic observed an unexpected increase in death.

The study authors determined that while the videos can be beneficial, health professionals should be attuned to the content to ensure what is consumed is not inaccurate or misleading.

Black patients had a 62% greater chance of having experienced an ischemic stroke pre-AF diagnosis, and a 67% higher risk of having one post-AF diagnosis.

Weight from age 25 onwards has been linked to the risk of more or less heart damage, as measured by levels of the protein troponin, underscoring the importance of long-term weight control.

The NeoTract product was originally indicated to treat those with BPH aged 50 years and older.

This is the first tentative approval of tenofovir alafenamide, coming just 2 years after the FDA approved Gilead Sciences' combination treatment of emtricitabine and tenofovir alafenamide.

Patients taking ustekinumab showed a 19% improvement in aortic inflammation compared to placebo.

The Stryker product is now cleared to be used up to 24 hours after symptom onset.

A newly released guideline for Canadian practitioners recommended against cannabinoids for most conditions, save for chronic neuropathic pain, chronic cancer-related pain, and refractory CINV and spasticity.

The National Institutes of Health has released data from the first 4500 patients in the ABCD study.

The PDUFA date has been set for June 20. In a previous trial of 22 patients, those on the Shire product reported a mean of 6.1 attacks compared with 12.7 with placebo

Following decades of research prohibition, physicians are once again raising the psilocybin question. This time, they’re letting data define the answer.

In a phase 3 trial, 89% of those assigned to rituximab plus short-term prednisone were completely in remission and off therapy in 24 months.

The Sandoz therapy now has received an indication for use in either 40 mg/mL or 20 mg/mL doses, with the lower quantity having been granted approval in June 2015.

Buprenorphine induction was associated with a 19.3% reduction in total outpatient costs, as well as better treatment adherence.

A study revealed that utilizing ride-sharing apps like Uber and Lyft only resulted in a 0.2% lower rate of missed primary care appointments.

The label update for secukinumab (Cosentyx, Novartis) now includes the treatment for moderate-to-severe scalp psoriasis.

The researchers only needed to correct from 30% to 50% of the cardiomyocytes to rescue the mutant phenotypes and restore near-normal function.

FDA Commissioner Scott Gottlieb released a statement deliniating the agency's concerns about the plant substance and its health consequences.

The 50-mg dose showed that 19.2% of patients were free of pain after 2 hours while the 100-mg dose resulted in 21.2% of pain-free patients.

The Embrace smartwatch allows patients with epilepsy to monitor for seizure activity without wearing an EEG

The approval has expanded ferumoxytol's indication to include all adults with iron deficiency anemia.